Staidson Biopharma Inc.
1 clinical trials · Sponsor
◉ Watch Staidson Biopharma Inc.
| Record | Firm | Date |
|---|---|---|
| The Safety and Tolerability of STSA-1005 Following Intravenous Infusion in Healthy Subjects (NCT05085197) | Staidson Biopharma Inc. | 2021-10-27 |
Track Staidson Biopharma Inc. automatically
Every clearance here is in the API, with alerts when new ones post.